RMS Medical Products Posts Third Quarter 2017 Results

The Company announced that its net revenues for the third quarter ended November 30 of fiscal 2017 were $3,193,113 compared with $3,144,954 for the third quarter of fiscal 2016. Net loss for the quarter was $104,275 compared with net income of $167,552 for the same period last year. For the nine months ended November 30, 2016, net loss was $420,204 compared with net income of $438,126. RMS continues to incur professional fees related to regulatory and litigation and has made significant investment over the last nine months in its sales, regulatory, quality and operations management, including hiring a Chief Medical Officer to help launch RMS to the next level of growth.

Read More